The effect of Alnus incana (L.) Moench extracts in ameliorating iron overload-induced hepatotoxicity in male albino rats

Iron overload causes multiorgan dysfunction and serious damage. Alnus incana from the family Betulaceae, widely distributed in North America, is used for treating diseases. In this study, we investigated the iron chelating, antioxidant, anti-inflammatory, and antiapoptotic activities of the total and butanol extract from Alnus incana in iron-overloaded rats and identified the bioactive components in both extracts using liquid chromatography-mass spectrometry. We induced iron overload in the rats via six intramuscular injections of 12.5 mg iron dextran/100 g body weight for 30 days. The rats were then administered 60 mg ferrous sulfate /kg body weight once daily using a gastric tube. The total and butanol extracts were given orally, and the reference drug (deferoxamine) was administered subcutaneously for another month. After two months, we evaluated the biochemical, histopathological, histochemical, and immunohistochemical parameters. Iron overload significantly increased the serum iron level, liver biomarker activities, hepatic iron content, malondialdehyde, tumor necrosis factor-alpha, and caspase-3 levels. It also substantially (P < 0.05) reduced serum albumin, total protein, and total bilirubin content, and hepatic reduced glutathione levels. It caused severe histopathological alterations compared to the control rats, which were markedly (P < 0.05) ameliorated after treatment. The total extract exhibited significantly higher anti-inflammatory and antiapoptotic activities but lower antioxidant and iron-chelating activities than the butanol extract. Several polyphenolic compounds, including flavonoids and phenolic acids, were detected by ultraperformance liquid chromatography-electrospray ionization-quadrupole time-of-flight mass spectrometry (UPLC-ESI-QTOF-MS) analysis. Our findings suggest that both extracts might alleviate iron overload-induced hepatoxicity and other pathological conditions characterized by hepatic iron overload, including thalassemia and sickle-cell anemia.

In vitro antioxidant activity.The butanol and total extracts revealed dose-dependent inhibition of 2,2-diphenyl-1-picrylhydrazyl (DPPH) activity with half-maximal inhibitory concentration (IC 50 ) values of 0.015 and 7.55 µg/ml, respectively.On the other hand, IC 50 in the petroleum ether and methylene chloride fractions was 229, and 29.06 µg/ml, respectively.All concentrations of both total extract and butanol fraction significantly inhibited the free radicals compared to methylene chloride and petroleum ether fractions (P < 0.05) (Fig. 1).Hence, we evaluated the potential ameliorative effects of total Alnus incana extract and butanol fraction against the hepatotoxicity induced by iron overload in male albino rats.
Total phenolic and flavonoid content.The total phenolic and flavonoid content of the total extract was found to be 125.88 ± 10.5 mg gallic acid equivalent (GAE) /g and, 122.4 ± 11.5 mg catechin equivalent (CE)/g respectively, while that of the butanolic fraction was 245 ± 18.5 GAE/g and 100 ± 9.8 mg CE/g, respectively (Table 2).

Acute toxicity study.
During the entire experimental period, no signs of acute toxicity and mortality were observed at doses up to 1000 mg/kg body weight (b.w.).Hence, the dose of butanol fraction was selected as 100 mg/kg b.w. for further studies.

Effect of treatment on serum liver function parameters.
Iron-overloaded group revealed a substantial (P < 0.05) decrease in the albumin and total protein levels and a marked (P < 0.05) rise in the total bilirubin level, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) activities compared to their controls (Table 4).Treatment with both extracts and the reference drug markedly (P < 0.05) elevated the albumin and total protein levels and significantly (P < 0.05) decreased the total bilirubin level, ALT, and AST activities compared to that of the iron-overloaded rats.Furthermore, the butanol extract showed substantially higher levels of the parameters mentioned above than the reference drug-treated rats.

Effect of treatment on both serum and hepatic iron content.
The iron-overloaded group revealed considerably higher serum and hepatic iron content than the control (P < 0.05).However, the administration of the total extract, butanol fraction, and deferoxamine to the iron-overloaded rats significantly decreased these parameters compared to the overloaded group (P < 0.05).The serum iron level in the butanol extract-treated rats was substantially lower than those in the total extract-treated rats (P < 0.05) without any significant difference (P > 0.05) from the levels in the reference drug-treated rats.The butanol extract treatment significantly decreased the hepatic iron content compared to those treated with the total extract and the reference drug (P < 0.05) (Fig. 2a and b).elevated the hepatic malondialdehyde (MDA) content and concomitantly reduced the hepatic reduced glutathione (GSH) content compared to their normal controls.While treatment with both extracts and the reference drug significantly reduced the MDA content and increased the GSH content compared to the iron-treated rats (P < 0.05).The reduction in the MDA level was markedly higher in the butanol extract than in the total extract.Contrarily, treatment with butanol extract did not show a significant difference (P > 0.05) in the GSH level compared to the control group (Fig. 2c and d).
Table 3. Secondary metabolites tentatively identified in A. incana total extract and butanol fraction using UPLC-ESI-QTOF-MS analysis.@ Percentage of each class of identified constituents in butanol fraction relative to total extract calculated from peak area.The percentage of abundance of each class was calculated by dividing the total peak areas of each class in butanol by total peak areas in total extract multiplied by 100.% of daidzein-8-C-glucoside, malvidin-3-glucoside and oregonin in butanol fraction as compared to the total extract, calculated from the peak area (573.69%,735.52%, 143.79% respectively).and f).Conversely, the administration of the total extract, butanol fraction, and the reference drug to ironoverloaded animals substantially reduced these parameters compared to the overloaded rats (P < 0.05).The rats treated with the total extract displayed significantly (P < 0.05) lower TNF-α level and caspase-3 activity than the butanol fraction-treated rats.

Histopathology
Light microscopy.The liver sections from the control rats displayed normal histological architecture.
The liver consisted of the central vein with regular hepatic plates separated by hepatic sinusoids.Each hepatic plate contained large polygonal hepatocytes with central, rounded, and vesicular nuclei (Fig. 3a).However, the iron-overloaded rats exhibited severe hepatic injury, including dilatation and congestion of the central vein and hepatic sinusoids, disarranged hepatic cords, hepatocellular degeneration with cytoplasmic vacuolization, yellow-brown iron deposits, inflammatory cells infiltration between hepatocytes and in the portal area along with dilatation and congestion of the portal vein (Fig. 3b-f).Conversely, the cotreated groups revealed marked attenuation in the iron overload-induced hepatic injury.The iron-overloaded rats cotreated with total extract of Alnus incana exhibited remarkable improvement in the histological structure with mild dilatation and congestion of the central vein and mild hepatocellular degeneration (Fig. 3g).The liver sections from group IV exhibited an apparently normal hepatic parenchyma with only mild dilatation and congestion of central vein and mild hepatocellular degeneration (Fig. 3h).Contrastingly, coadministration with deferoxamine markedly restored the hepatic parenchyma with straightly arranged hepatic cords, moderate dilatation, and congestion of central vein along with mild hepatocellular degeneration and cytoplasmic vacuolization (Fig. 3i).
Our results (Table 5) showed that the highest histopathological lesion score was observed in the iron-overloaded group (II).Contrastingly, the cotreated groups (III, IV, and V) revealed a marked reduction in all microscopic lesion scores.
Prussian blue staining.Prussian staining was performed to visualize the distribution of iron deposits in the hepatic tissue sections and confirm the variation between the different experimental groups.The liver sections from the control group displayed no iron deposits (Fig. 4a).Conversely, the blue pigment represented the iron deposits in the cytoplasm of the hepatocytes, interstitium, and portal area in the other treated groups (Fig. 4b-m).The highest hepatic iron accumulation was observed in the iron-overloaded rats (Fig. 4b-d) with a mean area % (33.92 ± 0.57, Fig. 4n) compared to other co-treated groups (Fig. 4e-m).Whereas treatment with total (Fig. 4e-g) and butanolic (Fig. 4h-j) extract as well as deferoxamine (Fig. 4k-m) markedly (P < 0.05) attenuated hepatic iron accumulation with mean area % (21.25 ± 0.78, 18.33 ± 0.59, and 22.59 ± 0.47, respectively, Fig. 4n).
Immunohistochemistry. Caspase 3. The liver sections from the iron-overloaded group (Fig. 5b) showed stronger positive immunoreactivity for caspase 3 than the control group (Fig. 5a).Whereas the iron-overloaded group cotreated with the total extract or butanol fraction or deferoxamine revealed moderate caspase 3 immunoreactivity compared to group II (Fig. 5c-e, respectively).

Discussion
Iron, an essential microelement, has several vital roles in living organisms 19,20 .However, iron overload, occurring due to poisoning, diseases, and pathological conditions, can induce multiorgan dysfunction, including liver damage 21 .The currently used iron-chelators such as deferiprone, deferoxamine, and deferasirox, cause several undesirable side effects, including agranulocytosis, neutropenia, gastrointestinal disturbances, and hepatic or renal failure 9,10 .These disadvantages of the current iron chelating agents highlight the innovation for alternative and safe pharmacological interventions.Ebrahimzadeh et al. 18 showed that herbal extracts with high phenolic content could act as chelators or adjuvants to treat iron overload.Therefore, here, we evaluated the antioxidant, iron chelating, anti-inflammatory, and antiapoptotic potentials of methanol extract from Alnus incana leaves and its butanol fraction against iron overload-induced hepatotoxicity.
Our results indicated that excess iron intake increased serum and hepatic iron levels, accompanied by significant alterations in liver function and lipid peroxidation.Subsequently, this resulted in deficient antioxidant defense mechanisms and apoptosis of the hepatic tissues.These findings align with Badria et al. 22 and Al-Basher 23 .www.nature.com/scientificreports/Based on our results, iron-overloaded rats revealed significantly elevated serum ALT and AST enzyme activities and total bilirubin levels but lower serum albumin and total protein, consistent with Al-Basher 23 .Furthermore, the hepatic iron content significantly correlated with hepatic serum ALT, AST, and total bilirubin level, where r = 0.845**, 0.813**, 0.910**, respectively (**P < 0.01).Whereas the hepatic iron content was negatively correlated with serum albumin, and total serum protein where r = − 0.87** and − 0.869**, respectively (**P < 0.01).These results were accompanied by a significant increase in the mean area % (33.92 ± 0.57) of hepatic iron accumulation as well as severe histopathological alterations in the form of dilatation, and congestion of central vein and hepatic sinusoids, disarranged hepatic cords, hepatocellular degeneration with cytoplasmic vacuolization, and inflammatory cells infiltration.These findings are consistent with Jahanshahi et al. 24 and Wang et al. 25 .The substantial elevation in liver function indicates liver injury, which subsequently affects hepatocyte's transport function, and leakage, resulting in the release of ALT and AST 26,27 .Furthermore, these histopathological alterations might affect hepatic functions and induce hypoalbuminemia and hypoproteinemia.Moreover, excessive iron content causes significant hepatocyte dysfunction, leading to the failure of normal uptake, conjugation, excretion, and subsequent rise in total bilirubin level 28 .
However, administration of both extracts markedly reduced the levels of AST, ALT activities, and total bilirubin and increased the albumin and total protein levels compared to the iron-overloaded rats.In the butanol extract-treated group, the parameters were restored to their normal ranges, accompanied by a marked reduction in the mean area % of the hepatic iron deposits with significantly improved hepatic parenchyma structure.These findings suggest the potent antioxidant effect of both extracts, as evidenced by the measurement of free radicals scavenging activity (Fig. 1).These antioxidant effects could be due to the presence of flavonoids and polyphenols in these extracts, which can stabilize and maintain the integrity of the liver cell membrane, stimulate hepatocyte regeneration, attenuate, and repair the damaged tissue, and subsequently enhance the enzymatic activity of liver and synthesis of hepatocellular proteins 29,30 .Furthermore, butanol administration significantly reduced the hepatic iron content compared to those treated with the total extract and the reference drug, suggesting that it has better iron chelation activity than total extract in the iron-overloaded rats.The phytochemical profiles of A. incana total extract and butanol fraction were identified using UPLC-ESI-QTOF-MS analysis.The data showed that the total extract and butanol fraction were rich in various polyphenols and diarylheptanoids.
The highest iron-chelating activity of the butanol fraction could be attributed to the greater abundance of daidzein-8-C-glucoside, malvidin-3-glucoside, and oregonin in this fraction than the total extract (Table 3).It has been reported that the aforementioned compounds exhibited iron-chelating activity via different mechanisms of action [31][32][33][34][35][36][37][38][39][40][41][42] .Additionally, flavonoids are the major identified class of constituents in A.incana extracts, and can chelate metals more efficiently than other polyphenols, suggesting that they can be used to potentially treat iron overload.According to Wang et al. 42 , flavonoids combat the accumulation of iron through three main mechanisms: (1) reducing iron saturation indirectly via multiple proteins and pathways, such as ferritin and hepcidin; (2) chelating iron to decrease iron accumulation, which directly decreasing iron saturation via binding sites, such as the 6, 7-dihydroxy structure, the B-ring catechol, and the 2, 3-double bond.Baicalin, baicalein, and quercetin have also been reported to exhibit significant iron-chelating activity; (3) oxidation resistance to diminish oxidative damage from iron overload by reacting with superoxide anion radicals to prevent free radicals' initiation, suppressing the Fenton reaction to prevent hydroxyl radical generation, and reacting with lipid peroxidation groups to prevent lipid peroxidation.This effect may be due to higher quantities of polyphenols in the butanol extract than in the total extract (Table 2).Polyphenols exert their antioxidant activities through different mechanisms including free radical scavenging potentials and iron binding.In general, transition metals involving iron promote the production of oxygen-free radicals, reduce peroxide, and interact with superoxide anions, resulting in oxidative stress.It has been found that polyphenols possess iron-binding abilities; these activities are primarily due to the presence of groups like catechol and galloyl.Besides, some investigations revealed that the 6,7-dihydroxy structure, B-ring catechol, the galloyl groups, the 2,3-double bond, and the 3-and 5-hydroxylic groups in co-existence with the 4-keto group are linked to chelation abilities, consequently, they are worthy of consideration as iron-binding sites 42 .
In this study, excess hepatic iron content induced a substantial (P ˂ 0.05) elevation in the hepatic MDA content along with a marked (P ˂ 0.05) decrease in the hepatic GSH level in the iron-overloaded groups compared to the control ones.These findings indicate oxidative stress via enhancement of lipid peroxidation, excess free radical formation, and deficient antioxidant mechanism, which subsequently leads to hepatic dysfunction and leakage of hepatic enzymes 43,44 .Papanikolaou and Pantopoulos 45 showed that excess iron creates free radicals, which induce damage to cellular macromolecules and potentiate cell death.Our results suggest a significant correlation between the hepatic iron content and MDA level (r = 0.798**) and a negative correlation between the hepatic iron content and GSH content (r = − 0.798**).Conversely, treatment with total extract and butanol fraction attenuated the induced oxidative stress as evidenced by a marked (P ˂ 0.05) elevation in GSH content and a significant (P ˂ 0.05) decline in MDA level compared to the iron-overloaded rats.These results might be attributed to the antioxidants found in both extracts.The butanol extract revealed greater antioxidant effects than the total extract.As this fraction contains higher polyphenol content (245 mg GAE/g) than the total extract (126 mg GAE/g, Table 2), the antioxidant activity correlates to the polyphenol concentration 46 .Natural polyphenols are potent antioxidants because they can scavenge free radicals, chelate metals, convert primary oxidation products to non-radical molecules, break the chain to prevent the continuous loss of hydrogen from substrates, and regulate antioxidant enzymes 47 .
Our study confirmed that iron overload-induced apoptosis manifested by potent caspase 3 immunoreactivity with markedly (P ˂ 0.05) elevated liver caspase 3 activity.This substantially correlated with the hepatic iron content.Previous research demonstrated that excess iron-induced oxidative stress which in turn caused damage to the inner mitochondrial membrane and initiated the opening of the mitochondrial pores.As a result, adenosine triphosphate (ATP) is depleted, and cytochrome c is released into cytosol that subsequently activates caspase 3 and induces cell death 8,48 .The activation of caspase 3, a crucial apoptosis mediator, causes DNA fragmentation and apoptotic chromatin condensation in the cells 49 .Therefore, excess iron promotes liver cell necrosis or apoptosis either alone or in combination with oxidative stress 48 .Furthermore, our results demonstrated that inflammation is another possible mechanism of iron overload-induced hepatotoxicity as the iron overload group revealed significantly (P ˂ 0.05) higher hepatic TNF-α activity accompanied by strong NF-κB immunohistochemical expression.Handa et al. 50reported that excessive iron supplementation induces oxidative stress in the liver cells, initiating both inflammatory and immune mediators as well as hepatocellular ballooning injury, which results in the prognosis of nonalcoholic steatohepatitis.TNF-α, a multifunctional cytokine, is crucial for various physiological and pathological mechanisms, including inflammation, apoptosis, and necrosis 51 .Furthermore, TNF-α activates NF-κB signaling pathways by activating toll-like receptors, resulting in increased immunohistochemical expression of NF-κB 52,53 .The activation of NF-κB can initiate and regulate the expression of a series of inflammatory cytokines implicated in inflammation 54,55 .Additionally, NF-κB is regulated by the excessive generation of ROS and many cytokines, including Interleukin-1 beta 56 .Our results demonstrated that both extracts have potent anti-inflammatory and antiapoptotic activities manifested by mild NF-κB immunoreactivity, moderate caspase 3 immune expression with substantially (P ˂ 0.05) lower liver TNF-α and caspase 3 activities than the iron-overloaded group.This might be attributed to the potent antioxidant capability of these extracts, along with their ability to chelate and inhibit hepatic iron contents.Moreover, the total extract exhibited higher anti-inflammatory and antiapoptotic activities than the butanol extract, possibly due to the synergistic effects of several polyphenolic compounds, including phenolic acids, flavonoids, stilbenes, coumarins, lignins, and tannins, which exhibit anti-inflammatory and antiapoptotic activities [57][58][59][60][61][62] .Besides, other classes, namely terpenoids and diarylheptanoids, displaying similar activities [63][64][65][66] were also detected in this extract (Tables 1 and 3).
Our results indicate that deferoxamine treatment significantly decreases the serum and hepatic iron contents and liver biomarkers (AST and ALT), consistent with Mansi et al. 20 , Jahanshahi et al. 24 , and Wang et al. 25 .Moreover, this treatment significantly reduced elevated levels of MDA, TNF-α, and caspase-3 and increased GSH contents, consistent with Wang et al. 25 .Furthermore, deferoxamine significantly attenuated the hepatic iron deposition, improved hepatic damage, and decreased caspase-3 and NF-κB immunoreactivity induced by the iron overload, which aligns with the observations by Jahanshahi et al. 24 and Wang et al. 25 .These results are attributed to its potent chelating activity.Heli et al. 67 reported that iron chelators could diminish oxidative stress by eliminating excess iron from the target tissues.

Conclusions
Our study demonstrated that both total and butanol extracts from Alnus incana could markedly chelate excessive iron and ameliorate the iron overload-induced hepatotoxicity in rats by reducing serum and hepatic iron contents, liver biomarker activities, diminishing oxidative stress, inhibiting inflammation and apoptosis, resulting in significantly higher serum albumin, total protein, and total bilirubin content, and improved endogenous antioxidant activity.Furthermore, they can alleviate the histopathological and histochemical alterations induced by iron overload due to their phytochemical contents.These findings suggest that both extracts might represent a novel treatment for iron overload-induced hepatoxicity and other pathological conditions characterized by hepatic iron overload, including thalassemia and sickle-cell anemia.

Materials and methods
Drugs and chemicals.All the chemicals were of high analytical grade and obtained from Sigma-Aldrich (St. Louis, MO, USA).Deferoxamine was purchased from Novartis Pharma AG (Basel, Switzerland).
Plant material.Alnus incana (L.) Moench leaves were collected with permission from Al Zoharia research garden following institutional, national, and international guidelines.Dr. Mamdouh Shokry, a botanist at Al Zoharia Research Garden in Cairo, Egypt, validated and authenticated the plant material.A voucher specimen was deposited at the herbarium of Pharmacognosy Lab, Faculty of Pharmacy (Girls), Al-Azhar University under the number (AR-2016).
Extract preparation.The air-dried plant material (1 kg) was extracted by thoroughly macerating it with 100% methanol (3×, 3 L) and filtered through filter paper (Whatman no. 1).The collected filtrate was dried under vacuum (45 °C) by rotary evaporator to obtain the total extract.Then, 350 g of the total extract had been suspended in distilled water, then successively fractionated using gradient polarity solvents, including petroleum ether, methylene chloride, and n-butanol.The fractions were filtered and evaporated by rotary evaporator using a suitable temperature to obtain the petroleum ether (60 g), methylene chloride (220 g), and n-butanol (12 g) fractions.
Phytochemical screening.We performed qualitative tests to detect the different phytochemical classes in the total and butanol extracts from Alnus incana leaves, according to 68 .
Determination of total phenolic and flavonoid content.The total phenolic content was determined using the Folin-Ciocalteu procedure 69 .The total flavonoid content was quantified using State Pharmacopeia of USSR 70 .

UPLC-ESI-QTOF-MS analysis of A. incana.
UPLC-ESI-QTOF-MS is a sophisticated and sensitive technique to identify secondary plant metabolites qualitatively and quantitatively.A negative ESI technique was applied to detect the various phytoconstituents in the A. incana total extract and butanol fraction.
The A. incana total extract and butanol fraction (100 mg) was dissolved in 2 mL of methanol: acetonitrile: water (1:1:2) by vortexing for 2 min and ultrasonicating for 10 min.After centrifuging for 10 min at 10,000 rpm, the solution was diluted to reach a final concentration of 2.5 µg/µL.Then, 10 µL was used for injection in the negative mode.The molecules were separated using an Axion AC system (Kyoto, Japan) linked to an autosampler system with an In-Line filter disk precolumn (0.5 µm × 3 mm, Phenomenex, USA) and an Xbridge C18 (3.5 µm × 2.1 mm × 50 mm) column (Waters Corporation, Milford, MA, USA) maintained at 40 °C and flow rate of 300 μL/min.Gradient elution was applied using the mobile phase, which consists of 5 mM ammonium formate in 1% methanol (pH = 8) and 100% acetonitrile.Triple TOF™ 5600 + system outfitted with a Duo Spray™ source operating in the ESI mode (AB SCIEX, Concord, Canada) was used for MS analysis.Following each scan, the top 15 intense ions were selected for obtaining the MS/MS fragmentation spectra.The target analytes were recognized by relating the LC/MS data with the reference database (ReSpect negative, 1573 records) and previously published compounds 71 .
In vitro antioxidant activity.The free radical scavenging potential of the extracts had been evaluated by the method described by 72 .IC 50 for all extracts was determined by probit analysis 73 .
Animals.Sixty male Wistar rats (210-230 g) were obtained from the National Organization for Drug Control and Research's animal house.They were kept under standard environmental conditions including a regular light/dark cycle (12/12 h), 25 °C ± 1 °C room temperature, and 50% ± 4% relative humidity.After acclimatizing for one week under a natural light cycle with adequate ventilation, they were fed a standard pellet diet and had unrestricted access to water.

Figure 1 .
Figure 1.DPPH scavenging activity of different A. incana extracts versus standard rutin.Data are expressed as mean ± SEM of three experiments.a Significantly different from petroleum ether extract, b Significantly different from methylene chloride extract.

Figure 2 .
Figure 2. Hepatic iron content (a), serum iron level (b), GSH (c), MDA (d), TNF-α (e), and Caspase-3 (f) levels among different experimental groups.C: Control group, Iron overloaded: Iron overloaded group, Iron overloaded + T: Iron overloaded + total extract-treated group, Iron overloaded + B: Iron overloaded + butanol fraction-treated group, Iron overloaded + D: Iron overloaded + deferoxamine-treated group.Results are expressed as Mean ± S.E.M (n = 6 rats/group).a significantly different from control, b significantly different from Iron overloaded group, c significantly different from Iron overloaded + B group, d significantly different from Iron overloaded + D group.

Figure 3 .
Figure 3. Representative photomicrographs of liver tissue sections of different experimental groups (H&E, × 400): (a) Control group displaying normal histological architecture of hepatic tissue with central vein (C.V.) and regular hepatic plates (arrow) separated by hepatic sinusoids (arrowhead) (b:f) Iron-overloaded group showing severe hepatic injury, including dilatation and congestion of central vein (star) and hepatic sinusoids (white arrowhead), disarranged hepatic cords, hepatocellular degeneration with cytoplasmic vacuolization (white arrow), yellow-brown iron deposits (yellow arrow), inflammatory cells infiltration between hepatocytes (circle) and in the portal area (yellow arrowhead) along with dilatation and congestion of portal vein (P.V.).(g:i) Cotreated groups (III, IV, and V) demonstrating marked attenuation in the iron overloadinduced hepatic injury accompanied by a decrease in the iron accumulation (yellow arrow).(g) Iron-overloaded group cotreated with total extract of Alnus incana exhibiting remarkable improvement in the histological structure with mild dilatation and congestion of the central vein (star) and mild hepatocellular degeneration (white arrow).(h) Iron-overloaded group cotreated with butanol extract of Alnus incana revealing an apparently normal hepatic parenchyma with only mild dilatation and congestion of central vein (star), and mild hepatocellular degeneration (white arrow).(i) Iron-overloaded group cotreated with deferoxamine markedly restored the hepatic parenchyma with straightly arranged hepatic cords (arrowhead), moderate dilatation, and congestion of central vein (star) along with mild hepatocellular degeneration and cytoplasmic vacuolization (white arrow).

Figure 4 .
Figure 4. Photomicrographs representing the distribution (a-m) and quantification (n) of Prussian blue stained iron deposits in the hepatic tissue sections of different groups.(a) Control group, (b:d) Iron overloaded group, (e:g) Iron overloaded group co-treated with total extract of Alnus incana, (h:j) Iron overloaded group co-treated with butanolic extract and (k:m) Iron overloaded group co-treated with deferoxamine.(a,b,e,h,k: × 100) (c,f,i,l: High magnification of the central area, × 400) (d,g,j,m: High magnification of the portal area, × 400).(n) Quantification of Prussian blue stain positive area % in the hepatic tissue of rats.Results are expressed as Mean ± S.E.M. a significantly different from control, b significantly different from Iron overloaded group, c significantly different from Iron overloaded + B group, d significantly different from Iron overloaded + D group.

Figure 5 .
Figure 5. Photomicrographs of caspase 3-stained liver sections from rats in the different experimental groups (× 400).(a) Control group, (b) Iron overloaded group, (c) Iron overloaded group co-treated with total extract of Alnus incana, (d) Iron overloaded group co-treated with butanol, and (e) Iron overloaded group co-treated with deferoxamine.

Figure 6 .
Figure 6.Photomicrographs of NFκB-stained liver sections from rats in the different experimental groups (× 400).(a) Control group, (b) Iron overloaded group, (c) Iron overloaded group co-treated with total extract of Alnus incana, (d) Iron overloaded group co-treated with butanol, and (e) Iron overloaded group co-treated with deferoxamine.

Table 2 .
Total phenolic and flavonoid content in total extract and butanol fraction from Alnus incana leaves.Results are expressed as mean ± SEM (standard error of the mean) of three replicate determinations.GAE Gallic acid equivalent, CE Catechin equivalent.

Table 4 .
Serum albumin, total protein, total bilirubin, ALT, and AST activities among different experimental groups.Results are expressed as mean ± SEM (standard error of the mean) (n = 6 rats/group).C: Control group, Iron overloaded: Iron overloaded group, Iron overloaded + T: Iron overloaded + total extract-treated group, Iron overloaded + B: Iron overloaded + butanol fraction-treated group, Iron overloaded + D: Iron overloaded + deferoxamine-treated group.ALT Alanine aminotransferase, AST Aspartate aminotransferase.a Significantly different from control, b Significantly different from Iron overloaded group, c Significantly different from Iron overloaded + D group, d Significantly different from Iron overloaded + T group.C Iron

overloaded Iron overloaded + T Iron overloaded + B Iron overloaded + D
ab Effect of treatment on hepatic TNF-α level, caspase-3 activity.Iron overload significantly increased the hepatic TNF-α level and caspase-3 activity compared to their control values (P < 0.05) (Figs.2e

Table 5 .
Pathological lesion scoring in the liver sections of different experimental groups.